|
N
|
59
|
102
|
112
|
112
|
36
|
104
|
|
Medical consultations (HS + Private), n (%)
|
|
GP
|
45 (76.3)
|
80 (78.4)
|
66 (58.9)
|
99 (88.4)
|
22 (61.1)
|
74 (71.2)
|
|
Specialists
|
59 (100.0)
|
81 (79.4)
|
112 (100.0)
|
94 (83.9)
|
34 (94.4)
|
104 (100.0)
|
|
A) HS consultations
|
|
Gastroenterologist, n (%)
|
59 (100.0)
|
51 (50.0)
|
112 (100.0)
|
67 (59.8)
|
23 (63.9)
|
104 (100.0)
|
|
Mean visits (95% CI)a
|
2.2 (1.8, 2.6)
|
2.0 (1.5, 2.4)
|
4.0 (3.1, 5.0)
|
2.3 (1.9, 2.7)
|
1.7 (1.4, 2.0)
|
2.7 (2.3, 3.0)
|
|
GP, n (%)
|
21 (35.6)
|
41 (40.2)
|
65 (58.0)
|
93 (83.0)
|
21 (58.3)
|
73 (70.2)
|
|
Mean visits (95% CI)a
|
4.2 (2.4, 6.0)
|
4.3 (3.2, 5.5)
|
6.4 (4.0, 8.7)
|
3.8 (2.9, 4.7)
|
2.1 (1.4, 2.7)
|
6.2 (4.2, 8.3)
|
|
B) Private consultations
|
|
Gastroenterologist, n (%)
|
19 (32.2)
|
46 (45.1)
|
33 (29.5)
|
47 (42.0)
|
12 (33.3)
|
4 (3.8)
|
|
Mean visits (95% CI)a
|
1.9 (1.1, 2.7)
|
2.7 (1.7, 3.7)
|
2.1 (1.6, 2.6)
|
2.2 (1.6, 2.8)
|
2.3 (1.4, 3.1)
|
2.0 (0.0, 4.3)
|
|
GP, n (%)
|
29 (49.2)
|
68 (66.7)
|
4 (3.6)
|
17 (15.2)
|
2 (5.6)
|
2 (1.9)
|
|
Mean visits (95% CI)a
|
3.9 (2.7, 5.0)
|
4.2 (3.2, 5.2)
|
3.1 (0.0, 6.4)
|
3.6 (2.3, 4.9)
|
1.5 (0.0, 7.9)
|
5.0 (0.0, 55.8)
|
|
Hospitalisations or emergency room visits
|
|
Any visit, n (%)
|
10 (16.9)
|
19 (18.6)
|
15 (13.4)
|
22 (19.6)
|
4 (11.1)
|
25 (24.0)
|
|
Number of hospitalisations, mean (95% CI)b
|
1.5 (0.9, 2.0)
|
2.4 (1.3, 3.4)
|
1.8 (0.7, 2.9)
|
1.3 (1.0, 1.6)
|
2.5 (0.0, 5.3)
|
1.7 (1.2, 2.3)
|
|
Median
|
1.0
|
1.0
|
1.0
|
1.0
|
2.1
|
1.0
|
|
Number of days hospitalised, mean (95% CI)b
|
5.7 (0.0, 12.2)
|
19.7 (3.2, 36.2)
|
17.9 (0.0, 41.6)
|
1.5 (0.6, 2.4)
|
10.7 (0.0,28.3)
|
11.8 (2.5, 21.1)
|
|
Median
|
3.1
|
9.0
|
6.0
|
1.5
|
12.0
|
6.0
|
|
Diagnostic tests
|
|
Any test n (%)
|
34 (57.6)
|
68 (66.7)
|
83 (74.1)
|
65 (58.0)
|
22 (61.1)
|
54 (51.9)
|
|
Number of tests, mean (95% CI)b
|
3.4 (2.4, 4.3)
|
4.0 (3.4, 4.6)
|
4.5 (3.9, 5.2)
|
4.1 (3.4, 4.7)
|
3.5 (2.5, 4.6)
|
3.6 (2.9, 4.4)
|
|
Median
|
2.5
|
3.5
|
4.0
|
4.0
|
3.0
|
3.0
|
|
Pharmacological therapies, n (%)
|
|
Prescription drug
|
31 (52.5)
|
73 (71.6)
|
54 (48.2)
|
95 (84.8)
|
33 (91.7)
|
97 (93.3)
|
|
Prescription drug for IBS-C
|
30 (50.8)
|
56 (54.9)
|
46 (41.1)
|
89 (79.5)
|
28 (77.8)
|
94 (90.4)
|
|
Non-prescription drug for IBS-C
|
36 (61.0)
|
71 (69.6)
|
92 (82.1)
|
63 (56.3)
|
25 (69.4)
|
66 (63.5)
|
|
Complementary therapies, n (%)
|
18 (30.5)
|
28 (27.5)
|
41 (36.6)
|
33 (29.5)
|
16 (44.4)
|
37 (35.6)
|
|
Absenteeism and work impairment questionnaire for employed patients (over one year)
|
|
Any sick leave taken, n (%)
|
12 (38.7)
|
19 (33.9)
|
15 (21.4)
|
14 (23.7)
|
12 (44.4)
|
33 (50.8)
|
|
Number of times on sick leave, mean (95% CI)c
|
3.3 (1.0, 5.6)
|
4.5 (3.0, 6.0)
|
6.9 (3.5, 10.2)
|
6.3 (1.9, 10.6)
|
5.7 (0.8, 10.6)
|
5.2 (3.8, 6.6)
|
|
Number of days on sick leave, mean (95% CI)c
|
64.1 (17.0, 111.2)
|
29.5 (10.5, 48.5)
|
11.6 (4.1, 19.2)
|
52.4 (0.0, 114.4)
|
51.3 (0.0, 113.6)
|
25.9 (12.7, 39.1)
|
|
Any work impairment while working, n (%)
|
16 (51.6)
|
37 (66.1)
|
18 (25.7)
|
31 (52.5)
|
19 (70.4)
|
53 (81.5)
|
|
Number of hours of work impairment, mean (95% CI)c
|
69.1 (22.0, 116.1)
|
140.4 (88.8, 192.0)
|
83.2 (18.4, 148.0)
|
54.8 (34.0, 75.7)
|
280.3 (146.5, 414.1)
|
161.9 (103.6, 220.2)
|
